To hear about similar clinical trials, please enter your email below
Trial Title:
Masseter Muscle Thickness in Gasser Ganglion Radiofrequency Treatment
NCT ID:
NCT06278194
Condition:
Trigeminal Neuralgia
Gasserian Ganglion; Lesion
Conditions: Official terms:
Ganglion Cysts
Synovial Cyst
Trigeminal Neuralgia
Neuralgia
Study type:
Interventional
Study phase:
N/A
Overall status:
Not yet recruiting
Study design:
Allocation:
N/A
Intervention model:
Single Group Assignment
Primary purpose:
Treatment
Masking:
None (Open Label)
Intervention:
Intervention type:
Procedure
Intervention name:
Gasserian Ganglion Radiofrequency Thermocoagulation
Description:
Gasserian ganglion radiofrequency thermocoagulation is performed in the operating room
under fluoroscopy. In sterile condition, the foramen ovale is shown by the pain
management specialist under fluoroscopy guidance. After this condition, the entry of the
needle is marked and anaesthetised with local anaesthetic. After the entry of the
gasserian ganglion with the radiofrequency needle, 10 cm long, the location is checked
with sensory and motor stimulation. If the placement is correct, 70 degrees 70 seconds of
radiofrequency thermocoagulation is applied.
Arm group label:
Patients treated with gasserian ganglion RFT for trigeminal neuralgia
Summary:
Trigeminal neuralgia is common painful disorder in pain medicine clinics. Gasserian
ganglion radiofrequency thermocoagulation is one of the treatment option in patients with
trigeminal neuralgia in refractory cases. The most commonly involved branch in trigeminal
neuralgia is the mandibular branch. Masseter muscle is innervated by mandibulary nerve
branch of the trigeminal nerve.
The radiofrequency thermocoagulation therapy is used to ablate the affected trigeminal
nerve branch and some of patients complain of subjective masseter weakness after this
procedure.
In theoretical basis, muscles innervated by target nerve are affected from ablation
procedure. In this study the primary aim is to evaluate the change of the masseter muscle
thickness in patients treated by gasserian ganglion radiofrequency thermocoagulation. The
results may also show possible functional effect of the procedure related with masseter
muscle.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Pain refractory to medical therapy for at least 3 months
- Planning radiofrequency thermocoagulation of gasserian ganglion
- Accept ultrasound measurements to be performed
Exclusion Criteria:
- Refused to participate in the study
- Not attending follow-ups regularly
- Coagulation disorder
- Pregnancy
- Localized or systemic infection
Gender:
All
Minimum age:
40 Years
Maximum age:
85 Years
Healthy volunteers:
No
Start date:
March 15, 2024
Completion date:
November 15, 2024
Lead sponsor:
Agency:
Başakşehir Çam & Sakura City Hospital
Agency class:
Other
Source:
Başakşehir Çam & Sakura City Hospital
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06278194